Analyst Observations
Published: February 25, 2026
This content is for informational purposes only. This should not be construed as solicitation. The general public should consult their financial advisor for additional information related to investment decisions.
Comments include: CAVA, CE, EMN, GE, IDXX, MP, MTRN, NVDA, & ORLY.

 

CAVA CAVA Group, Inc. ($84.69) - Restaurants - CAVA reversed into Xs and broke a double top at $71 to complete a bullish triangle as shares rallied to $85, marking the highest chart level since August last year. The stock is a 3 for 5'er that ranks within the top third of the Restaurants sector matrix. From here, those seeking exposure are best to look for price consolidation along with a normalization of the 10-week trading band before considering. Prior resistance at $72 may be seen as near-term support, while additional can be found at $67.
CE Celanese Corporation ($49.15) - Chemicals - After giving four consecutive buy signals CE fell to a sell signal Wednesday when it broke a double bottom at $52; the move adds to an already weak technical picture as CE is a 2 for 5'er. From here, the next level of support sits at $44.
EMN Eastman Chemical Company ($75.62) - Chemicals - After giving six consecutive sell signals EMN fell to a sell signal Wednesday when it broke a double bottom at $75. Wednesday's move adds evidence to a weak outlook as EMN is a 2 for 5'er. From here, the next level of support sits at $69.
GE GE Aerospace ($343.88) - Aerospace Airline - Quick follow-up to our most recent comment- GE moved higher today, printing new all-time highs today in the process. The technical picture remains quite strong and the notable change that comes with today's action is the establishment of new support around a range of old resistance in the $320's. Those who were waiting to see if $344 was trouble can feel a bit more comfortable moving in here.
IDXX IDEXX Laboratories, Inc. ($660.62) - Healthcare - IDDX inched higher and completed a double top break at $656. The 4 for 5'er moved down from a 5 earlier this month, after reversing back into Os against the market, and sits over 10% below its highs from late 2025. However, IDDX is still rated a buy and ranks int the top half of the healthcare sector matrix. Consider adding exposure here, or wait for the stock to move closer to its previous all-time highs. Strong support can be seen at $608. Strong resistance can be seen at $720.
MP MP Materials Corp. ($59.06) - Metals Non Ferrous - After giving five consecutive sell signals, MP returned to a buy signal Wednesday when it completed a bearish signal reversal at $59. The outlook for the stock remains unfavorable, however, as MP is a 0 for 5'er that ranks 19th of 21 names in the metals non ferrous sector matrix. From here, the first level of support sits at $54.
MTRN Materion Corp. ($161.67) - Chemicals - MTRN returned to a buy signal Wednesday when it broke a double top at $160. Wednesday's move adds to an already positive technical picture as MTRN is a 4 for 5'er that ranks in the top third of the chemicals sector matrix. From here, initial support lies at $144, while overhead resistance can be found at $172, MTRN's all-time high.
NVDA NVIDIA Corporation ($196.92) - Semiconductors - NVDA pushed higher ahead of its earnings release to break a double top at $194 before reaching $196 intraday. This moves the stock back to a positive trend and promotes it to a 3 for 5 TA rating. The weight of the technical evidence is still mixed, as the stock is in a defined range between the upper $190s and the lower $170s.
ORLY O'Reilly Automotive, Inc. ($91.31) - Autos and Parts - ORLY broke a triple bottom at $91 for a second sell signal since the beginning of February. The stock continues to maintain a 3 technical attribute rating, but now ranks within the bottom half of the Autos and Parts sector matrix. From here, the next level of support lies at $90, while the bullish support line resides at $87.
Back to report

DISCLOSURE

This report is for Internal Use Only and not for distribution to the public. While we make every effort to be free of errors in this report, it contains data obtained from other sources. We believe these sources to be reliable, but we cannot guarantee their accuracy. Investors who use options should read the Options Disclosure Document before making any particular investment decision. Officers or employees of this firm may now or in the future have a position in the stocks mentioned in this report. Dorsey, Wright is a Registered Investment Advisor with the U.S. Securities & Exchange Commission. Copies of Form ADV Part II are available upon request.
Equity prices provided by Thomson-Reuters. Cross Rate prices provided by Tenfore Systems. Option prices provided by OPRA
Copyright © 1995-2026 Dorsey, Wright & Associates, LLC.®
All quotes displayed are delayed 20 minutes
Disclaimer/Terms of Use/Copyright